Abstract:ABSTRACT The objectives of this study are to examine the disparities in serum and intestinal tissue metabolites between a perimenopausal rat model and control rats and to analyze the diversity and functionality of intestinal microorganisms to determine the potential correlation between intestinal flora and metabolites. We established a rat model of perimenopausal syndrome (PMS) and performed an integrated analysis of metabolome and microbiome. Orthogonal partial least-squares discriminant analysis scores and replacement tests indicated distinct separations of anion and cation levels between serum and intestinal samples of the model and control groups. Furthermore, lipids and lipid-like molecules constituted the largest percentage of HMDB compounds in both serum and intestinal tissues, followed by organic acids and derivatives, and organoheterocyclic compounds, with other compounds showing significant variability. Moreover, analysis of diversity and functional enrichment of the intestinal microflora and correlation analysis with metabolites revealed significant variability in the composition of the intestinal flora between the normal control and perimenopausal groups, with these differentially expressed intestinal flora strongly correlated with their metabolites. The findings of this study are expected to contribute to understanding the indications and contraindications for estrogen application in perimenopausal women and to aid in the development of appropriate therapeutic agents. IMPORTANCE In this work, we employed 16S ribosomal RNA gene sequencing to analyze the gut microbes in stool samples. In addition, we conducted an ultra-high-performance liquid chromatography-tandem mass spectrometry-based metabolomics approach on gut tissue and serum obtained from rats with perimenopausal syndrome (PMS) and healthy controls. By characterizing the composition and metabolomic properties of gut microbes in PMS rats, we aim to enhance our understanding of their role in women’s health, emphasizing the significance of regulating gut microbes in the context of menopausal women’s well-being. We aim to provide a theoretical basis for the prevention and treatment of PMS in terms of gut microflora as well as metabolism.

Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration.

Estrogen-gut microbiome axis: Physiological and clinical implications

Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction

Gene-environment interaction in functional hypothalamic amenorrhea

From Gut to Hormones: Unraveling the Role of Gut Microbiota in (Phyto)Estrogen Modulation in Health and Disease

Endometrial Dysbiosis: A Possible Association with Estrobolome Alteration

A local audit evaluating bone health in patients with functional hypothalamic amenorrhoea secondary to an eating disorder and a review of the application of hormone therapy in this clinical setting

Electroacupuncture Combined with Diet Treatment Has a Therapeutic Effect on Perimenopausal Patients with Abdominal Obesity by Improving the Community Structure of Intestinal Flora

Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice

Gut Microbiome–Estrobolome Profile in Reproductive-Age Women with Endometriosis

Synbiotic effects of β-glucans from cauliflower mushroom and Lactobacillus fermentum on metabolic changes and gut microbiome in estrogen-deficient rats

Study on gut microbiota and metabolomics in postmenopausal women

Gut Microbiota and Acylcarnitine Metabolites Connect the Beneficial Association between Estrogen and Lipid Metabolism Disorders in Ovariectomized Mice

The effects of weight loss-related amenorrhea on women's health and the therapeutic approaches: a narrative review

Estradiol and high fat diet associate with changes in gut microbiota in female ob/ob mice

Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention

High-fat diet and estrogen modulate the gut microbiota in a sex-dependent manner in mice

Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats

Effects of the gut microbiota and its metabolite short-chain fatty acids on endometriosis

Integrated analysis of metabolome and microbiome in a rat model of perimenopausal syndrome

Estradiol-mediated protection against high-fat diet induced anxiety and obesity is associated with changes in the gut microbiota in female mice